Rethinking Nicotine.

For private educational use only

shared for the members & guests of: The Private Members Association

---

Disclaimer: This article has not been approved by Dr. Bryan Ardis. It reflects our private interpretation of the insights he has shared, combined with additional research and reflections. It is offered for educational and discussion purposes only.

---

---

Dr. Bryan Ardis has been raising important questions about how nicotine may function as a protective agent in the body—especially in response to certain toxins and engineered exposures. His message challenges the public narrative and invites us to take a second look.

In simple terms, he proposes this: Nicotine, when used in clean forms such as patches, lozenges, or gum, may block harmful interactions at the cellular level by occupying receptor sites (ACE2 and nicotinic acetylcholine receptors). This may reduce the body’s vulnerability to certain venom-like peptides and other synthetic agents.

In his interviews, Dr. Ardis refers to multiple peer-reviewed studies—not just speculation. These studies explore:

• How nicotine binds to nicotinic acetylcholine receptors (nAChRs)

• Its potential role in blocking venom peptide activity

• Its effects on reducing neurological inflammation and cytokine response

---

Peer-Reviewed Science to Explore

Below are several reputable sources that outline nicotine’s possible therapeutic applications. These are not endorsements—only shared for educational purposes within the private domain.

1. “A Nicotinic Hypothesis for COVID-19”

   Changeux, Jean-Pierre et al.

   Read on PubMed Central

   
   

   This article proposes that disrupted nicotinic receptor activity may be part of COVID-19 pathology, and nicotine could play a protective role.

   
   

2. “Nicotine and the Nicotinic Cholinergic System in COVID-19”

   Farsalinos, K. et al.

   Read on PubMed

   
   

   Details how nicotine could influence immune modulation and reduce severity of certain symptoms.

   
   

3. Search: “Nicotine neuroprotection venom nicotinic receptor”

   
   

   Various studies have explored how nicotine may counteract certain neurotoxins, including snake venom peptides.

   
   

4. Peer-Reviewed Compilation on Therapeutic Nicotine Use

   View full article

   Nicotine has been studied as a potential therapy in:

• Parkinson’s disease

• Alzheimer’s

• Ulcerative colitis

• Schizophrenia

• Attention disorders

• plus more…

---

Understanding the Confusion

Much of the our fear of nicotine comes from this false equation:

Nicotine = Smoking = Cancer

But that’s not accurate. Here’s what the evidence shows:

• Cigarette smoke contains thousands of toxic additives, including heavy metals, tar, and combustion byproducts.

• Nicotine itself is not carcinogenic when isolated and delivered cleanly.

• It occurs naturally in small amounts in foods like tomatoes, potatoes, and peppers.

• While mildly habit-forming on its own, nicotine becomes far more addictive when combined with MAO inhibitors found in cigarette smoke.

---

How Some Are Using Nicotine as a Wellness Tool

Again, this is not a recommendation. But in private circles, individuals are exploring the low-dose, non-combustible forms such as:

• Transdermal patches (3 mg)

Reported private uses include:

• Enhancing mental clarity or focus

• Supporting protection against certain peptides or spike-related symptoms

• Managing neurological inflammation and long-haul fatigue

• Increased white blood cell motility has been noticed in members when using transdermal patches (no known study, observed within our private community)

---

A Note of Caution and Respect

This isn’t suitable for everyone. If you are pregnant, have cardiovascular sensitivity, or have a low threshold for stimulants, use discernment. As with any natural compound, the context, awrging size, and form all matter. In the right conditions and for the right terrain, nicotine may serve as a functional tool—not a crutch, not a habit.

Resources to Share or Explore Further

1. Dr. Ardis Interview Library

   
   

   Visit: https://www.brighteon.com/channels/drardis

   
   

   Search keyword: nicotine

   
   

2. Qeios Article – Nicotine Hypothesis

   
   

   Quick overview for laypersons and practitioners alike:

   
   

   https://www.qeios.com/read/article/592

   
   

3. PubMed Search – Nicotine Protection Studies

   
   

   To browse more clinical literature:

   
   

   https://pubmed.ncbi.nlm.nih.gov/?term=nicotine+covid+protection

---

for more information: text PATCHES to 403.461.2423